Available and emerging treatments for Parkinson's disease: a review.
Publication
, Journal Article
Hickey, P; Stacy, M
Published in: Drug design, development and therapy
January 2011
Parkinson's disease is a commonly encountered neurodegenerative disorder primarily found in aged populations. A number of medications are available to control symptoms, although these are less effective in advanced disease. Deep brain stimulation provides a practicable alternative at this stage, although a minority of patients meet the strict criteria for surgery. Novel medications that provide enhanced symptomatic control remain in developmental demand. Both gene and cell-based therapies have shown promise in early clinical studies. A major unmet need is a treatment that slows or stops disease progression.
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Drug design, development and therapy
DOI
EISSN
1177-8881
ISSN
1177-8881
Publication Date
January 2011
Volume
5
Start / End Page
241 / 254
Related Subject Headings
- Parkinson Disease
- Humans
- Genetic Therapy
- Deep Brain Stimulation
- Antiparkinson Agents
- Animals
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hickey, P., & Stacy, M. (2011). Available and emerging treatments for Parkinson's disease: a review. Drug Design, Development and Therapy, 5, 241–254. https://doi.org/10.2147/dddt.s11836
Hickey, Patrick, and Mark Stacy. “Available and emerging treatments for Parkinson's disease: a review.” Drug Design, Development and Therapy 5 (January 2011): 241–54. https://doi.org/10.2147/dddt.s11836.
Hickey P, Stacy M. Available and emerging treatments for Parkinson's disease: a review. Drug design, development and therapy. 2011 Jan;5:241–54.
Hickey, Patrick, and Mark Stacy. “Available and emerging treatments for Parkinson's disease: a review.” Drug Design, Development and Therapy, vol. 5, Jan. 2011, pp. 241–54. Epmc, doi:10.2147/dddt.s11836.
Hickey P, Stacy M. Available and emerging treatments for Parkinson's disease: a review. Drug design, development and therapy. 2011 Jan;5:241–254.
Published In
Drug design, development and therapy
DOI
EISSN
1177-8881
ISSN
1177-8881
Publication Date
January 2011
Volume
5
Start / End Page
241 / 254
Related Subject Headings
- Parkinson Disease
- Humans
- Genetic Therapy
- Deep Brain Stimulation
- Antiparkinson Agents
- Animals
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences